Alkyl Amines Chemicals Ltd Q2 FY22 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- The company experienced a challenging first half of the year but is optimistic about better performance in upcoming months.
- New projects like the Acetonitrile plant (starting production shortly) and the higher amines plant in Kurkumbh (expected by end of 2022) will contribute to revenue growth.
- Expansion plans include a Rs. 600-700 crore CAPEX over the next 2-3 years to increase capacities.
- Aliphatic amines capacity is expected to increase by about 30% after the Kurkumbh plant comes on stream.
- Acetonitrile capacity will increase from about 12,000 tons to 30,000 tons per year.
- Exports have been strong recently and are expected to play a larger role in turnover going forward.
- The government PLI scheme and efforts to diversify supply chains away from China are expected to positively impact the pharma-related demand.
- Overall, the company expects improved sales growth driven by capacity expansions and favorable market dynamics.
See what Alkyl Amines Chemicals Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
- No explicit mention of any current or planned fundraising through debt or equity is indicated in the provided transcript.
- The company is undertaking CAPEX of around Rs. 170-200 crore this year and next year, funded likely through internal accruals or existing resources.
- The management discusses ongoing and future expansion plans, including setting up new plants but does not mention raising funds from debt or equity markets.
- Land acquisition for future expansions is considered but no reference to fundraising is made.
- Overall, the transcript focuses primarily on operational updates, raw material prices, and capacity expansions without discussing fundraising activities.
See what Alkyl Amines Chemicals Ltd management said on order book — free account, 30 seconds.
Capex plans
Yes- Planned CAPEX of approximately Rs. 1.7 billion for the current year and next year.
- New aliphatic amines project under construction at Kurkumbh with a project cost of around Rs. 350-360 crore, expected to be commissioned by end of 2022.
- Continuous debottlenecking and brownfield expansion of DMA HCL capacity ongoing, resulting in yearly capacity increases.
- Recently commissioned a new Acetonitrile plant (Rs. 160 crore investment) which has started production.
- Other small projects including a hydrogen plant are due for commissioning within the next 6 months.
- Looking for additional land parcels of 70-150 acres for future expansions beyond September 2023, but currently have sufficient land until that time.
- Future investments also planned based on R&D developments to introduce new products aligning with COVID treatment drug requirements.
Track Alkyl Amines Chemicals Ltd — get its next earnings analysis in your feed
Margin guidance
Category 3- Management expects improved performance in coming months after a challenging first half of FY22.
- New Acetonitrile plant commissioning starting production adds to topline and bottom line.
- Higher Amines plant at Kurkumbh (one of the largest globally) to come on stream end of 2022, increasing aliphatic amines capacity by ~30%.
- Ongoing capacity expansions and debottlenecking of DMA HCL to steadily increase output.
- CAPEX of approximately Rs. 350-360 crore for higher amines and Rs. 170-200 crore annually over next two years planned for expansion and new projects.
- Expected benefit from stabilized raw material prices after peak inflationary pressures.
- Export volumes expected to increase, supported by new capacities and easing logistics.
- Positive industry outlook driven by Pharma sector growth, supply chain diversification away from China, and government initiatives like PLI scheme.
- Overall, earnings and profits are expected to grow as new capacities ramp up and price stabilization occurs.
Order book
How does Alkyl Amines Chemicals Ltd rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Alkyl Amines Chemicals Ltd rank in Chemicals & Petrochemicals?
Compare Alkyl Amines Chemicals Ltd against every Chemicals & Petrochemicals company (Q2 FY22) on revenue, margins and earnings-call signals.
Continue your research
What Alkyl Amines Chemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
- Deepak Fertilis. (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…